
Photos of Jessica J Lin and Sarah Waliany
Jul 4, 2024, 03:53
Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib
Sarah Waliany, Thoracic Oncology Fellow at Mass General Cancer Center, shared the following post by Stephen V Liu, on X:
“Thank you Stephen V Liu! Enjoyed working with Jessica J Lin on reviewing the TRUST-1 trial investigating taletrectinib and the evolving landscape of therapies for ROS1+ NSCLC. So important that we continue to develop effective and tolerable therapies for these patients. ”
Quoting Stephen V Liu‘s post:
“Love the figures from the recent ROS1 editorial in Journal of Clinical Oncology from Drs. Sarah Waliany and Jessica J Lin as they provide perspective on the TRUST trial and talectrectinib for ROS1+ NSCLC.”
Source: Sarah Waliany/X and Stephen V Liu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 23, 2025, 11:45
Feb 23, 2025, 11:37
Feb 23, 2025, 11:30
Feb 23, 2025, 11:30
Feb 23, 2025, 11:22
Feb 23, 2025, 10:34
Feb 23, 2025, 10:29